|
Jul 2
|
Top Analyst Reports for Johnson & Johnson, Home Depot and Micron
|
|
Jul 2
|
Does J&J's Innovative Medicine Unit Hold the Key to Q2 Sales Growth?
|
|
Jul 1
|
Johnson & Johnson (JNJ) Rises As Market Takes a Dip: Key Facts
|
|
Jul 1
|
A Promising Depression Drug Works. Psychedelics Are Back.
|
|
Jul 1
|
Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)?
|
|
Jul 1
|
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
|
|
Jul 1
|
Should iShares Core High Dividend ETF (HDV) Be on Your Investing Radar?
|
|
Jun 30
|
PJM Appoints Deena O'Brien as Senior Director of Communications
|
|
Jun 30
|
The Hackett Group® Announces Winners of the 2025 Hackett Innovation Awards
|
|
Jun 27
|
Here's What to Expect From Johnson & Johnson's Next Earnings Report
|
|
Jun 27
|
Johnson & Johnson Is Great. Here's Why You Shouldn't Buy It.
|
|
Jun 27
|
How PepsiCo, Johnson & Johnson, And Skyworks Solutions Can Put Cash In Your Pocket
|
|
Jun 27
|
Why JNJ Is a Long-Term Winner
|
|
Jun 26
|
J&J's MedTech Segment Slowing Down: Will its Sales Recover in 2025?
|
|
Jun 26
|
Want Decades of Passive Income? 5 Stocks to Buy Now and Hold Forever
|
|
Jun 26
|
Retinitis Pigmentosa Research Report 2025: $25+ Bn Market Opportunities and Strategies to 2034 - Gene Therapy Poised as Fastest Growing Treatment Segment, Strategic Collaborations Drive Advancements
|
|
Jun 26
|
J&J teams with Nvidia, Amazon on fund for AI surgery solutions
|
|
Jun 25
|
Johnson & Johnson CAR T Therapy Shows 80% Response in Lymphoma Trial
|
|
Jun 25
|
Johnson & Johnson (JNJ) Launches Two New Plating Systems in the US
|
|
Jun 25
|
Johnson & Johnson MedTech Expands VOLT Platform With New Wrist, Upper Arm Fracture Systems
|